Gilead Sciences Inc (GILD)
65.44
-0.11
(-0.17%)
USD |
NASDAQ |
May 07, 16:00
65.44
0.00 (0.00%)
After-Hours: 17:54
Gilead Sciences Shares Outstanding: 1.247B for March 31, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
March 31, 2024 | 1.247B |
March 15, 2024 | 1.247B |
February 29, 2024 | 1.245B |
February 16, 2024 | 1.246B |
December 31, 2023 | 1.246B |
October 31, 2023 | 1.246B |
September 30, 2023 | 1.247B |
July 31, 2023 | 1.246B |
June 30, 2023 | 1.247B |
April 28, 2023 | 1.247B |
March 31, 2023 | 1.248B |
March 15, 2023 | 1.249B |
February 28, 2023 | 1.247B |
February 17, 2023 | 1.247B |
December 31, 2022 | 1.247B |
October 31, 2022 | 1.254B |
September 30, 2022 | 1.254B |
July 29, 2022 | 1.253B |
June 30, 2022 | 1.254B |
April 29, 2022 | 1.254B |
March 31, 2022 | 1.255B |
March 15, 2022 | 1.256B |
February 28, 2022 | 1.253B |
February 18, 2022 | 1.254B |
December 31, 2021 | 1.254B |
Date | Value |
---|---|
October 29, 2021 | 1.254B |
September 30, 2021 | 1.255B |
July 30, 2021 | 1.254B |
June 30, 2021 | 1.254B |
April 30, 2021 | 1.254B |
March 31, 2021 | 1.254B |
March 19, 2021 | 1.259B |
February 26, 2021 | 1.257B |
February 18, 2021 | 1.257B |
December 31, 2020 | 1.254B |
October 30, 2020 | 1.254B |
September 30, 2020 | 1.253B |
July 31, 2020 | 1.254B |
June 30, 2020 | 1.254B |
April 30, 2020 | 1.254B |
March 31, 2020 | 1.254B |
March 13, 2020 | 1.259B |
February 28, 2020 | 1.260B |
February 18, 2020 | 1.264B |
December 31, 2019 | 1.266B |
October 29, 2019 | 1.265B |
September 30, 2019 | 1.266B |
June 30, 2019 | 1.266B |
April 30, 2019 | 1.272B |
March 31, 2019 | 1.274B |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
1.245B
Minimum
Feb 29 2024
1.266B
Maximum
Jun 30 2019
1.253B
Average
1.254B
Median
Mar 31 2020
Shares Outstanding Benchmarks
Amgen Inc | 536.43M |
CymaBay Therapeutics Inc (DELISTED) | 114.78M |
Bristol-Myers Squibb Co | 2.027B |
Eli Lilly and Co | 950.41M |
Xilio Therapeutics Inc | 34.47M |